Madrigal Pharmaceuticals, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of MDGL for the last quarter is 62.17 M USD, and it's 324.75% higher compared to the previous quarter. The net income of Q3 24 is -106.96 M USD.